SANA 0013
Alternative Names: SANA-0013; SANA-013Latest Information Update: 16 Oct 2023
At a glance
- Originator Wesana Health
- Class Antidepressants; Antimigraines; Anxiolytics; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Anxiety disorders; Cluster headache; Depressive disorders; Major depressive disorder; Migraine; Traumatic brain injuries; Trigeminal neuralgia